Astria Therapeutics Inc (ATXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,322 | -17,460 | -7,952 | -26,293 | -19,683 |
| Accounts payable and accrued liabilities | 211 | -26 | -501 | -211 | 682 |
| Other Working Capital | 2,771 | 2,272 | 612 | -1,870 | -393 |
| Other Operating Activity | 916 | 759 | 852 | 1,805 | 595 |
| Operating Cash Flow | $-24,424 | $-14,455 | $-6,989 | $-26,569 | $-18,799 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 26,333 | 24,333 | -15,432 | -4,070 | -578 |
| PPE Investments | -23 | -23 | N/A | -12 | N/A |
| Investing Cash Flow | $26,310 | $24,310 | $-15,432 | $-4,082 | $-578 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 40,829 | 31,889 | 25,624 | 25,620 | 21,848 |
| Financing Cash Flow | $40,829 | $31,889 | $25,624 | $25,620 | $21,848 |
| Beginning Cash Position | 10,376 | 10,376 | 10,376 | 15,407 | 15,407 |
| End Cash Position | 53,091 | 52,120 | 13,579 | 10,376 | 17,878 |
| Net Cash Flow | $42,715 | $41,744 | $3,203 | $-5,031 | $2,471 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,424 | -14,455 | -6,989 | -26,569 | -18,799 |
| Capital Expenditure | -23 | -23 | N/A | -12 | N/A |
| Free Cash Flow | -24,447 | -14,478 | -6,989 | -26,581 | -18,799 |